GSK’s Flixonase campaign wins SMI Supreme Marketing Award 

EditorNews Make a Comment

GlaxoSmithKline Consumer Healthcare marketers Jeremy Ritson and Faliesha Pound won the Supreme Award at Friday’s 9th NZ Self-Medication Industry Association Marketing Awards in Auckland, for the company’s Flixonase allergy relief brand campaign. 

Executive director Scott Milne says this year presented the highest standard of entries they had ever seen in the contest.

“It was particularly pleasing to see how complementary medicines are raising the bar with evidence-based research, one of SMI’s key goals going forward,” he said.

The winning campaign, which successfully moved the Flixonase nasal-spray treatment brand from general sale to pharmacy-only, also won the award for Best Integrated Marketing Campaign of a Consumer Healthcare Product.

Joint runners-up in this category were Good Health’s Julia van de Coolwijk for the Good Health Turmeric Extra Strength campaign and Vitaco Health NZ’s Priscilla Khor for Nutra-Life Kyolic Aged Garlic campaign.


“The campaign significantly increased market share in a highly competitive and complex allergy market.”


“The Supreme Award winner was an outstanding campaign that really covered all the bases well,” said judge Tim Roper.

“Shifting the category from grocery to pharmacy is not easy but they managed it seamlessly. The campaign significantly increased market share in a highly competitive and complex allergy market.”

The trophy for Best Launch or Relaunch of a Consumer Healthcare Product went to Menarini’s Elizabeth Jaray and Insight NZ’s James White for their Rejuvenail fungal nail treatment campaign. GSK marketers Jeremy Ritson and Faliesha Pound came runners-up in this category for their Voltaren Osteo launch.

RBNZ’s Sarah Hollander won the award for Best Digital Campaign for Durex marketing.


Share this Post